CHICAGO--(BUSINESS WIRE)--Allscripts Healthcare Solutions, Inc. announced today that, effective January 1, 2023, it has changed its name to Veradigm Inc. (NASDAQ: MDRX). Allscripts had been ...
Allscripts announces Veradigm AccelRxâ„¢ to help reduce patient wait times for specialty medications
CHICAGO--(BUSINESS WIRE)--Allscripts Healthcare Solutions (NASDAQ:MDRX) has unveiled a unique new software solution for specialty medication management, delivered by Veradigmâ„¢, its business unit ...
What looks to be a small wine fridge is tucked away inconspicuously in the corner of Veradigm’s 12th floor office in the Flatiron neighborhood of Manhattan. But rather than bottles of burgundy, the ...
Allscripts’ payer and life sciences division Veradigm tapped Surescripts to help streamline patient enrollment for specialty medication prescriptions. Allscripts’ specialty medication management ...
CHICAGO, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Today, Allscripts (NASDAQ: MDRX) announced Veradigm as the new branding for Allscripts’ Payer & Life Sciences division. Veradigm is a leader in providing ...
The life sciences leg of the Veradigm data analytics business is gaining traction as the industry shifts to real-world evidence as a fundamental pillar of drug discovery, Allscripts executives said.
The name change, effective Jan. 1, has been underway since 2022, as Allscripts worked to move its products to the new brand, according to a Jan. 3 press release from the company. All remaining ...
Allscripts life sciences arm Veradigm is teaming up with Microsoft in an attempt to change the way clinical trials are conducted. The aim is to develop an integrated research model that allows trial ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results